The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
Christopher Mapperley(MRC Centre for Regenerative Medicine), Kamil R. Kranc(Queen Mary University of London), Ivayla Ivanova(Edinburgh Genomics), David Wotherspoon(Queen Mary University of London), J Paris(Queen Mary University of London), Adam J. Mead(National Institute for Health and Care Research), Andrea Tavosanis(Springer Nature (Germany)), Annika Sarapuu(Queen Mary University of London), Marcos Morgan(MRC Centre for Regenerative Medicine), Alex von Kriegsheim(Edinburgh Cancer Research), Jozef Durko(Queen Mary University of London), Hannah Lawson(University of London), Richard I. Gregory(Boston Children's Hospital), Joana Campos(Queen Mary University of London), Dónal O’Carroll(MRC Centre for Regenerative Medicine), Christian Much(MRC Centre for Regenerative Medicine), Louie N. van de Lagemaat(Queen Mary University of London), Junho Choe(Harvard University), Daniela S. Krause(German Cancer Research Center)
Cited by 145
Related Papers
Tyrosine Kinases as Targets for Cancer Therapy
|New England Journal of Medicine|2005|1.4k
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
|Cell stem cell|2019|552
The RNA m 6 A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence
|Molecular Cell|2017|404
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
|Molecular Cell|2021|359
Germline selection shapes human mitochondrial DNA diversity
|Science|2019|251